1. Snake Venom Metalloproteinases (SVMPs) {#sec1}
=========================================

Snake Venom Metalloproteinases (SVMPs) are zinc-dependent enzymes that have been described in the venoms of snakes, particularly from species in the *Viperidae* family and *Crotalinae* subfamily ([@bib50], [@bib48], [@bib47]). Additionally, the distribution of SVMPs can be extended to the venoms of *Elapidae*, *Atractaspididae* and *Colubridae* snake families, although in these families, SVMPs are found in smaller concentrations ([@bib26]; [@bib54]; [@bib78]; [@bib121]; [@bib151], [@bib150]). Recent studies have showed that the presence of SVMPs in certain venoms could be related to environmental features such as the climate, which in turn influences snake foraging strategies ([@bib154]; [@bib165]). Snakes that live in an environment with milder winters and less seasonal variation in temperature have a haemotoxic venom mostly composed by SVMPs. These data indicate that epigenetic factors influence the evolution of toxins, having an impact in the field of snake genomics and consequently affecting the relationship between SVMPs structures and its functions.

Features such as variation in domain composition, functional diversity and possibility of class recombination of SVMPs have frustrated previous attempts to resolve and harmoniously incorporate newly discovered SVMPs into the known classes. For instance, the initial classification of SVMPs divided them into four classes based on the cDNA/mRNA sequences of their precursors (N-classification or Nucleotide-based classification) or the size of the mature proteins purified from the snake venoms (P-classification or Protein-based classification) ([@bib10]; [@bib65]). The N--I or Metalloproteinase class I has the simplest sequence, which is encoded by a signal sequence, a pro-domain and a metalloproteinase domain. The N--I transcripts resulted in the P--I class of proteins that had only the metalloproteinase domain. The N-II class encoded a signal, a pro-domain, a metalloproteinase and a disintegrin domains giving rise to the mature proteins of the P-II class (metalloproteinase and disintegrin domains). Differently, the N-III class encoded a disintegrin-like domain instead of the disintegrin domain and an additional cysteine-rich domain. The N-III nucleotide sequences resulted in the mature proteins of the P-III class. The last class, the N-IV, encompassed an additional lectin-like domain, giving rise to P-IV proteins ([@bib10]; [@bib65]). However, N-IV transcripts have never been found in the transcriptomes of snake venom glands, so this classification is no longer used ([@bib10]; [@bib105]).

The most adopted SVMP classification dates from 2008 and it classifies the metalloproteinases into three classes: P--I (20--30 kDa) containing a metalloproteinase domain in its mature form; P-II (30--60 kDa; P-IIa, P-IIb, P-IIc, P-IId and P-IIe) containing a disintegrin domain linked to the C-terminus of the metalloproteinase domain, and P-III (60--100 kDa; P-IIIa, P-IIIb, P-IIIc and P-IIId) consisting of a metalloproteinase domain, a disintegrin-like and a cysteine rich domains ([@bib49]). The lack of proteomic evidence and the non-observation of a P-IV mRNA transcript led to the merge of the P-IV class into the P-III class (P-IIId) with the suggestion that the P-IV class represents a post translational modification of the accepted P-III structure with the addition of a lectin-like domain ([@bib49], [@bib50]; [@bib89]). [Fig. 1](#fig1){ref-type="fig"} shows a general scheme of the canonical structures peculiar to each SVMP class before and after maturation.Fig. 1A general scheme of the canonical structures peculiar to each SVMP class. **1A** depicts immature SVMPs and it encompasses a P--I class containing peptide signal sequence (PS), pro-domain (PD) and metalloproteinase (M) domain; P-II consist of PS, PD, M, spacer sequence (SS) and disintegrin (D) domain; and P-III contains PS, PD, M, SS, disintegrin-like (D) and cysteine rich (C) domains. **1B** delineates processed SVMPs (without PS and PD). Thus, canonical structure of the matured P--I consists of only the M domain; P-II contains M, SS and D domains; and P-III is comprised of M, SS, D and C domains.Fig. 1

1.1. SVMPs classification {#sec1.1}
-------------------------

### 1.1.1. The P--I SVMPs {#sec1.1.1}

The P--I class includes the smallest and simplest metalloproteinases with molecular masses ranging from 20 to 30 kDa and the presence of only a metalloproteinase (M) domain when isolated from the snake venom ([@bib89]; [@bib126]). The M domain has a conserved zinc-binding sequence (HEXXHXXGXXH) followed by a conserved "Methionine-turn" motif ([@bib32]; [@bib63]). P--I members have the ability to degrade basement membrane components, which corresponds to their proteolytic, hemorrhagic and edema forming activities ([@bib120]; [@bib142]). However, as P--I SVMPs only have the M domain, studies demonstrated that they have a diffuse localization in the extracellular matrix, and consequently a less toxic effect than P-II or P-III SVMPs ([@bib142]).

Many studies have characterized proteins belonging to the P--I class, including their crystal structures ([@bib3]; [@bib7]; [@bib27]; [@bib44]; [@bib56], [@bib55]; [@bib57]; [@bib70]; [@bib79]; [@bib85]; [@bib87]; [@bib117]; [@bib161]; [@bib166]). [@bib133] and [@bib148] were the first to report the complete sequences of two representatives of the P--I class: Ht-d and H~2~-proteinase ([@bib133]; [@bib148]). Early characterization of Ht-d, a hemorrhagic metalloproteinase from the venom of the western diamond-black rattlesnake *Crotalus atrox*, showed that this P--I representative has a molecular mass of 23,234 Da ([@bib133]). In the same year, structural analysis of peptides resulting from digests with cyanogen bromide, lysyl endopeptidase, trypsin, *Staphylococcus aureus* V8 protease and thermolysin revealed the primary structure and the position of the disulfide linkage in the non-hemorrhagic H~2~-proteinase from habu snake (*Trimeresurus flavoviridis*) ([@bib148]). The same study also demonstrated that the P--I H~2~-proteinase is a non-glycosylated single chain polypeptide with an approximate size of 23 kDa (22,991 Da) and 201 amino acid residues.

In general, P--I members present high similarity in their structures, but a wide variation regarding their hemorrhagic activity ([@bib16]). Data from molecular dynamic simulations showed differences in the structures of hemorrhagic and non-hemorrhagic P--I SVMPs ([@bib156]). The main difference was associated with the flexibility and rigidity of the loop near the active site. Briefly, non-hemorrhagic P--I members have great flexibility in the loop region after the Met-turn whereas hemorrhagic P--I members have higher flexibility in the loop area before the Met-turn. This differential flexibility can be responsible for the unequal hemorrhagic activity found in this class, having a role in protein-protein interaction at the basement membrane ([@bib16]; [@bib156]).

An extensive review that punctuated the structure and biological activity of SVMPs mentioned the characterization of the crystal structures of 10 members of the P--I class: Atrolysin C, Acutolysin A, BapI, Fibrolase, HT-2, Atroxase, LHF-II, H~2~-proteinase, HR2A and Gramminelysin I; whose biological activities include hemorrhage, mionecrosis, inflammation, fibrinolysis, non-hemorrhagic proteolysis, and apoptosis ([@bib47]). After this review, other P--I members were characterized such as the non-hemorrhagic FII from *Agkistrodon acutus* ([@bib87]), the non-hemorrhagic Leucurolysin-A from *Bothrops leucurus* ([@bib44]), Batx-I from *Bothrops atrox* ([@bib117]), BpirMP from *Bothrops pirajai* ([@bib7]), the hemmorrhagic okinalysin from *Ovophis okinavensis* ([@bib77]), the fibrinolytic and hemorrhagic proteins jararafibrase III (21,400 ± 500 Da) and jararafibrase IV (21,200 ± 400 Da) from the venom of *Bothrops jararaca* (Maruyama et al.), bothrojararactivase (22, 829 Da), BJ-PI (\~ 25 kDa) and Bj-PI2 (28 kDa) also from *B. jararaca* venom ([@bib6]; [@bib32]; [@bib112]). Bothrojaractivase stands out due to its pronounced prothrombin-activating activity, while BJ-PI displays high fibrinogenolytic and caseinolytic effect. Bj-PI2 lacks myonecrotic and hemorrhagic activity although it has the ability to recruit inflammatory cells and degrade fibrin ([@bib6]; [@bib32]; [@bib112]). In another study, two P--I SVMPs, BpMP-I and BpMP-II, were characterized from the venom of *Bothrops pauloensis.* The non-hemorrhagic BpMP-I is a 20 kDa P--I that exhibits fibrinogenolytic activity while BpMP-II (23 kDa) was observed to inhibit cell adhesion and angiogenesis ([@bib108]). Although there was no positive correlation between the presence of BpMP-II and local tissue hemorrhage, its azocaseinolytic activity has also been reported ([@bib1]). [Table 1](#tbl1){ref-type="table"} describes a list of the most well-known P--I SVMPs.Table 1P--I SVMPs representatives and their reported activities.Table 1SVMP (P--I)Molecular Mass (kDa)Snake SpeciesReported ActivitiesReferences**1.**HR2A23.02*Trimeresurus flavoviridis*Hemorrhagic[@bib96], [@bib143]**2.**HT-225*Crotalus ruber*Hemorrhagic and fibrinogenolytic[@bib103]**3.**HT-325.50*Crotalus ruber*Hemorrhagic and fibrinogenolytic[@bib103]**4.**Atroxase23.50*Crotalus atrox*Non-hemorrhagic and fibrinolytic[@bib162]**5.**Ht-d23.23*Crotalus atrox*Hemorrhagic (degradation of fibronectin, laminin, type IV collagen, nidogen, and gelatins)[@bib133]; Uniprot**6.**H~2~-proteinase22.99*Trimeresurus flavoviridis*Non-hemorrrhagic and proteolytic[@bib148]**7.**LHF-II22.3*Lachesis muta*Hemorrhagic, caseinolytic fibrinolytic and fibrinogenolytic[@bib125]**8.**Jararafibrase III21.4*Bothrops jararaca*Fibrinolytic and hemorrhagic[@bib90]**9.**Jararafibrase IV21.2*Bothrops jararaca*Fibrinolytic and hemorrhagic[@bib90]**10.**Adamalysin II24*Crotalus adamenteus*Endopeptidase, non-hemorrhagic, and inactivates serpins by limited proteolysis of their reactive-site loops[@bib55]; Uniprot**11.**BapI24*Bothrops asper*Weakly hemorrhagic, fibrinogenolytic, caseinolytic and fibrinolytic[@bib60]**12.**Acutolysin A22*Agkistrodon acutus*Hemorrhagic[@bib57]**13.**GramminelysinI27.02*Trimeresurus gramineus*Fibrinogenolytic and apoptotic[@bib163]**14.**EoVMP124*Echis ocellatus*Non-hemorrhagic and activates prothrombin (procoagulant)[@bib67], [@bib68]**15.**Agkislysin22*Agkistrodon acutus*Fibrinogenolytic, fibrinolytic and prothrombin-activating[@bib160]**16.**Insularinase22.64*Bothrops insularis*Fibrinogenolytic, fibrinolytic and prothrombin-activating[@bib34]**17.**FII26 kDa*Agkistrodon acutus*Non-hemorrhagic[@bib87]**18.**BjussuMP-II24*Bothrops jararacussu*Antiplatelet, non-hemorrhagic, gelatinolytic, collagenolytic, fibrinolytic and fibrinogenolytic[@bib88]**19.**BnP124*Bothrops neuwendi*Fibrinolytic and\
fibrinogenolytic[@bib4]**20.**Bothrojararactivase22.83*Bothrops jararaca*Prothrombin-activating[@bib6]**21.**Bj-PI\~ 25*Bothrops jararaca*Fibrinogenolytic and caseinolytic[@bib112]**22.**Leucurolysin-A23*Bothrops leucurus*Non-hemorrhagic and non-glycosylated-fibrinogenase[@bib44]**23.**CcH125*Cerastes cerastes*Hemorrhagic[@bib12]**24.**Batx-123.3*Bothrops atrox*Fibrinogenolytic and\
Hemorrhagic[@bib117]**25.**Bj-PI228.08*Bothrops jararaca*Non-hemorrhagic and fibrinolytic. It can recruit inflammatory cells[@bib32]**26.**BpMP-I20*Bothropoides pauloensis*Non-hemorrrhagic and fibrinogenolytic[@bib108]**27.**BpirMP23.1*Bothrops pirajai*Thrombocytic,\
fibrinogenolytic and fibrinolytic[@bib7]**28.**BmooMPα-I22.6*Bothrops moojeni*Kininogenase[@bib111]**29.**Okinalysin22*Ovophis okinavensis*Caseinolytic and hemorrhagic[@bib77]**30.**BpMP-II23*Bothropoides pauloensis*Azocaseinolytic.\
It can inhibit cell adhesion and angiogenesis[@bib1]**31.**Bar-I23.39*Bothrops barnetti*Non-hemorrhagic, fibrinogenolytic and fibrinolytic[@bib125]

1.2. The P-II SVMPs {#sec1.2}
-------------------

The P-II class is structurally more complex than the P--I class but less than those of the P-III class. Several studies from the cDNA sequences have shown that the P-II class contains multiple domains including a pro-domain (PD; non-matured proteins), a metalloproteinase (M) domain and a disintegrin (D) domain ([@bib15]; [@bib25]; [@bib50], [@bib49]; [@bib47]; [@bib110]; [@bib146]). The derived P-II members have been only purified from the venoms of snakes belonging to the *Viperidae* family, which suggests that they emerged from a P-III SVMP precursor that lost its cysteine-rich domain, after the divergence of *Viperidae* from the *Elapidae* family ([@bib18]; [@bib127]). Additionally, the disintegrin domain of P-II SVMPs may have been lost on diverse moments, forming the P--I SVMPs ([@bib19]).

P-II class members have molecular masses ranging from 30 to 60 kDa and a number of proteins belonging to this class have already been described ([@bib19]). Although the arrangement of the domains is the same in all the P-II members, there is a variation in the length of the spacer sequence between the metalloproteinase and disintegrin domains and in the pattern of cysteines. P-II SVMPs possess 12 cysteine residues that are uniquely patterned, but some members such as agkistin ([@bib159]) and albolamin ([@bib72]) have two additional cysteine residues. A report in the literature revealed that the disintegrin domain, which abutted the C-terminal segment of the metalloproteinase domain could be vulnerable to proteolytic release ([@bib64]). However, this proteolytic processing could be prevented by the presence of 2-additional cysteine residues capable of forming disulfide bonds, which gives stability to the structure, thereby hindering auto-proteolysis of the C-terminal segment of the metalloproteinase domain ([@bib47]). Additionally, the pattern of cysteine in different domains of P-II SVMPs can be responsible for their diversities as such pattern, in addition to stability, may contribute to unique folding and dimerization. As previously noted, the current classification scheme ([Fig. 2](#fig2){ref-type="fig"}) recognizes 5 sub-classes of P-II SVMPs including P-IIa, P-IIb, P-IIc, P-IId and P-IIe ([@bib49]).Fig. 2Sub-classification of matured P-II SVMPs. The P-IIa consists of a processed fragment of metalloproteinase (M) and another fragment of disintegrin (D). The P-IIb is canonical and it is comprised of M, spacer sequence (SS) and D domain. Members of the P-IIc sub-class are dimers; each monomer is a canonical form. Dimerization of two identical disintegrins give rises to the P-IId sub-class; whereas in the P-IIe, non-identical disintegrins form dimers.Fig. 2

One unique feature of the members of the P-II class is the presence of an integrin-binding motif usually called RGD-motif (RGD stands for arginine-glycine-aspartate). The RGD-motif is not totally conserved in all P-II members. There are copious reports of RGD variants such as KGD (lysine-glycine-aspartate), VGD (valine-glycine-aspartate), WGD (tryptophan-glycine-aspartate), MLD (methionine-leucine-aspartate), RTS (arginine-threonine-serine), KTS (lysine-threonine-serine) and so on ([@bib14]; [@bib21]; [@bib123]). The RGD-motif is embedded in a flexible loop constituted by the oligopeptide chain of 13 aminoacyl residues, which interact significantly with the integrin α~IIB~β~3~/GpIIb/IIIa inhibiting platelet aggregation ([@bib29]; [@bib91]).

In some P-II structures, additional intra-chain interaction culminate to structural reinforcement and stability, thus, preventing the proteolytic release of their disintegrins. Sequence alignment and phylogenetic analysis revealed this feature in jerdonitin, a 36 kDa protein purified from the venom of *Trimeresurus jerdonii* ([@bib25]). Additionally, the presence of the RGD-motif in jerdonitin enhanced its ability to inhibit ADP-induced human platelet aggregation in a dose-dependent fashion ([@bib25]). In another report, two P-II proteins, TJM-1 and TJM-2, were isolated from the venom of *Trimeresurus jerdonii* and comparative analysis has revealed the presence of additional Cys-407 and Cys-426 in TJM-2. More recently, [@bib72] reported the cloning of albolamin from a cDNA library obtained from the green pit viper *Cryptelytrops albolaris* venom gland ([@bib72]). Western blot probe using anti-polyhistidine antibody revealed that the recombinant protein has a molecular mass of approximately 35 kDa and it belongs to the P-II class SVMP. In addition to the conserved RGD-integrin binding motif present in the disintegrin domain, albolamin also contains two additional cysteine residues in its structure, which may prevent auto-proteolysis of the protein ([@bib72]). Activity report showed that albolamin could degrade human collagen type IV and inhibit collagen-induced platelet aggregation in a dose dependent manner ([@bib72]).

Continuous advancements in recombinant DNA technology have provided scientists with tools for the characterization of more protein structures. For instance, there was the successful cloning of the ahpfibrase from the venom of *Gloydius halys* ([@bib167]). This P-II protein has 32 kDa and contains the canonical RGD-motif, which is responsible for platelet aggregation inhibition, besides its fibrinolytic activity ([@bib167]). In addition, [@bib159] cloned the P-II agkistin from the venom of *Agkistrodon halys* and demonstrated that this protein of 57 kDa (as shown by Western blot profiling) inhibited ADP-induced platelet aggregation and induced apoptosis in Human Uterine Microvascular Endothelial Cells (HUMEC) ([@bib159]). Sequence determination and structural analysis revealed the presence of the RGD motif in the disintegrin domain of agkistin and the presence of two cysteine residues (Cys 407 and Cys 426) in addition to the 12 uniquely patterned cysteine residues of P-II members ([@bib159]).

As mentioned previously, there are several reports showing that some members of the P-II SVMP class do not contain the canonical RGD motif ([@bib14]; [@bib21]; [@bib123]). While some motifs share similarities, others are too varied and since the RGD motif is responsible for inhibition of platelet aggregation, members lacking this motif may have different activities and functions. For example, the primary structure of bilitoxin-1, a P-II SVMP of 32 kDa from *Agkistrodon bilineatus*, revealed that this hemorrhagic protein lacks platelet aggregation inhibitory activity and this may be due to the presence of a MGD binding sequence contrary to the canonical RGD motif ([@bib110]). Notwithstanding, the MGD motif has been shown to impair the function of α~5~β~1~ integrin ([@bib14]). On the other hand, peptide mass fingerprinting and protein sequence revealed that the presence of the KGD motif in the disintegrin domain of stejnitin did not affect its ability to inhibit ADP-induced platelet aggregation ([@bib61]). This 35 kDa protein was purified from the venom of *Trimeresurus stejnegeri*. DNA fragmentation alongside flow cytometry analysis demonstrated that it could trigger apoptosis in ECV304 cells ([@bib61]). [@bib137] reported the isolation of the recombinant P-II albolatin from the venom of *Trimeresurus albolaris.* Expression analysis of the D domain showed the presence of a KGD motif that does not interfere with the inhibition of collagen-induced platelet aggregation ([@bib137]). In a similar case, the dimeric BlatH1 (84 kDa), isolated from *Bothriechis lateralis*, hydrolyzed fibrinogen, gelatin and azocasein and it inhibited both ADP- and collagen-induced platelet aggregation ([@bib15]). In fact, this protein lacks the conventional RGD-integrin-binding motif, which was replaced by the TDN (threonine-aspartate-asparagine) motif ([@bib15]). CcMP-II, a 35 kDa hemorrhagic P-II protein purified from *Cerastes cerastes* snake venom, has the ability to inhibit platelet aggregation and it has been shown to hydrolyze ECM components such as type IV collagen and laminin, besides possessing α-fibrinogenase activity ([@bib13]).

Several studies have cloned and expressed the disintegrin domain of P-II SVMPs. For instance, Dis*Ba*-01 ([@bib122]), bothrostatin ([@bib43]), BnMPIIx (neuwiedin) ([@bib84]) and CamVMPII (r-cam-dis) ([@bib140]) were identified from cDNA libraries constructed from the venom transcriptome of four different snake species: *Bothrops alternatus, Bothrops jararaca, Bothrops neuwiedi and Crotalus adamanteus*, respectively. SDS-PAGE analyses showed that bothrostatin, CamVMPII and Dis*Ba*-01 are proteins of approximately 8 kDa ([@bib122]). Although MALDI-TOF analysis showed that BnMPIIx has a molecular mass of 8 kDa, data from SDS-PAGE fingerprint correlated this protein to a molecular mass of 14 kDa ([@bib84]). It was demonstrated that BnMPIIx inhibited ADP-induced platelet aggregation whereas bothrostatin inhibited collagen-induced platelet aggregation. CamVMPII inhibited both processes ([@bib140]). The inability of BnMPIIx to inhibit collagen-induced platelet aggregation may be due to a unique cysteine sequence and the substitution of some residues at the C-terminal of its RGD binding loop. Dis*Ba*-01, a recombinant RGD-disintegrin, demonstrated a α~v~β~3~ integrin blocking effect ([@bib122]). In fact, recent data from [@bib33] demonstrated that Dis*Ba*-01 interfered in the α~v~β~3~/VEGFR2 crosstalk, culminating into inhibition of HUVEC adhesion, migration and VEGF-mediated angiogenesis ([@bib33]). Other examples of cloned disintegrins containing a RGD-motif are: trigamin (*Trimeresurus gramineus*), a platelet aggregation inhibitor ([@bib109]), jerdonin (*Trimeresurus jerdonii*), an antagonist of the platelet GPIIb-IIIa receptor ([@bib170]), bitistatin (*Bothrops arietans*), a platelet aggregation inhibitor that binds to the α~IIb~β~3~ integrin (([@bib76]), insularin (*Bothrops insularis*), an inhibitor of endothelial cell adhesion ([@bib38]) and salmosin 1 (*A. h. brevicandus*), that inhibited the binding of α~IIb~β~3~ integrin to fibrinogen ([@bib75]; [@bib116]). A summary of P-II SVMPs members is described in [Table 2](#tbl2){ref-type="table"}.Table 2P-II SVMP members and their reported activities.Table 2SVMP\
(P-II)M Mass (kDa)Domain Composition (As Studied)Snake SpeciesIntegrin-binding MotifReported ActivitiesReferences**1.**Trigamin9Disintegrin*Trimeresurus gramineus*RGDInhibition of platelet aggregation[@bib70], [@bib109]**2.**Salmosin 17.5Disintegrin*A. h. brevicandus*)RGDInhibition of α~IIb~β~3~ integrin binding to fibrinogen[@bib75], [@bib116]**3.**Atrolysin E/D7.4Disintegrin*Crotalus atrox*MVDInhibition of both ADP- and collagen-induced platelet aggregations[@bib134]**4.**Bilitoxin-132.28Dimeric; each monomer contains metalloproteinsase, and disintegrin*Agkistrodon bilineatus*MGDHemorrhagic[@bib110]**5.**Jerdonitin36Metalloproteinase and disintegrin*Trimeresurus jerdonii*RGDInhibition of ADP-induced human platelet aggregation[@bib25]**6.**Agkistin\~57Metalloproteinase and disintegrin.*Agkistrodon halys*RGDInhibition of ADP-induced platelet aggregation and induction of apoptosis in HUMEC[@bib159]7**.**Jerdonin7.5Disintegrin*Trimeresurus jerdonii*RGDAntagonist of the platelet\'s GPIIb-IIIa receptor[@bib170]8**.**Bitistatin9Disintegrin*Bothrops arietans*RGDInhibition of platelet aggregation via binding to the α~IIb~β~3~ integrin[@bib76]9**.**Bothrostatin8Disintegrin*Bothrops jararaca*RGDInhibition of collagen-induced platelet aggregation[@bib43]**10.**Stejnitin35Metalloproteinase and disintegrin*Trimeresurus stejnegeri*KGDInhibition of ADP-induced platelet aggregation and induction of apoptosis in ECV304 cells[@bib61]**11.**Albolatin\
(only the disintegrin domain)11Homodimeric disintegrins*Trimeresurus albolaris*KGDInhibition of collagen-induced platelet aggregation[@bib137]**12.**Dis*Ba*-018Disintegrin*Bothrops alternatus*RGDα~v~β~3~ -- blocking effect and inhibition of angiogenesis in HUVEC[@bib33], [@bib122]**13.**Ahpfibrase32Metalloproteinase and disintegrin*Gloydius halys*RGDFibrinolytic activity and inhibition of platelet aggregation[@bib167]**1**4**.**Insularin14Disintegrin*Bothrops insularis*RGDInhibition of endothelial cell adhesion[@bib38]**15.**CamVMPII (r-cam-dis)8Disintegrin*Crotalus adamanteus*RGDInhibition of both ADP- and collagen-induced platelet aggregation[@bib140]**16.**Albolamin35Metalloproteinase and disintegrin*Cryptelytrops albolaris*RGDDegradation of human collagen type IV and inhibition of collagen-induced platelet aggregation[@bib72]**1**7**.**BlatH184Dimeric; each monomer contains metalloproteinsase, and disintegrin*Bothriechis lateralis*RGDInhibition of both ADP- and collagen-induced platelet aggregation;\
hemorrhagic, fibrinogenolytic, gelatinolytic and azocaseinolytic[@bib15]**1**8**.**BnMPIIx (neuwiedin)8.18Disintegrin*Bothrops neuwiedi*RGDInhibition of ADP-induced platelet aggregation[@bib84]19**0.**CcMP-II\
Boukhalfa-35Metalloproteinsase, and disintegrin*Cerastes*Hemorrhagic and\
α-fibrinogenase activity[@bib13]

1.3. The P-III SVMPs {#sec1.3}
--------------------

The P-III class of SVMP encompasses a group of diverse proteins with higher molecular masses, usually ranging from 60 to 100 kDa and having a more complex structure than P--I and P-II SVMPs ([@bib89]). Members of the P-III class are widely distributed in the venoms of the *Viperidae*, *Elapidae*, *Atractaspididae* and *Colubridae* families ([@bib19]), supporting the studies that indicate that P-III SVMPs are derived from an early recruitment, duplication and neofunctionalization of an ancestral ADAM gene, before the radiation of the advanced snakes (\~ 60 million years ago) ([@bib18]; [@bib20]; [@bib51]). P-III class comprise a pro-domain (PD), metalloproteinase (M), disintegrin-like (D) and cysteine-rich (C) domains. The presence of the non-catalytic disintegrin-like domain and the cysteine rich domain in the P-III class accounts for their potent hemorrhagic activities ([@bib42]). For instance, VaH4 is a hemorrhagin purified from the venom of *Vipera ammodytes ammodytes.* This protein is extremely hemorrhagic -- hydrolyzing extracellular matrix components such as fibronectin, nidogen and the α-chain of fibrinogen -- and possesses a potent cytotoxic activity against HeLa cells ([@bib81]).

Due to its structural complexity, the P-III class was further classified into four subclasses: P-IIIa, P-IIIb, P-IIIc and P-IIId ([@bib49]). The P-IIIa is considered the canonical subclass and it encompasses members containing a metalloproteinase, disintegrin-like and cysteine rich domains after post-translational exclusion of its pro-domain ([@bib49]). A representative member of this subclass is the protein ohagin, a 50 kDa fibrinogenolytic protease isolated from the venom of *Ophiophagus Hannah* ([@bib59]). The P-IIIb subclass comprises proteins that had undergone post-translational cleavage and/or proteolytic processing, which releases a mature form containing a disintegrin-like domain (with a D/ECD motif) and a cysteine-rich domain [@bib49]; [@bib89]. A representative member of this subclass is the protein Alternagin isolated from the venom of *Bothrops alternatus* ([@bib139]). Alternagin inhibits α~2~β~1~ integrin, thereby decreasing cell adhesion to type I collagen ([@bib128]) and interferes with the α~2~β~1~/VEGFR2 crosstalk, thus inhibiting angiogenesis in HUVECs ([@bib41]). Other example of the P-IIIb subclass is the protein TSV-DM purified from *Trimeresurus stejnegeri* venom wich potentially induces apoptosis on vascular endothelial cells ([@bib157]). In the P-IIIc subclass of SVMPs, some members are able to form dimers. VaH3 is a P-IIIc hemorrhagin purified from the venom of *Vipera ammodytes ammodytes* ([@bib124])*.* Data from MALDI/TOF analysis suggest that it has a molecular mass of 104 kDa in its non-reduced form, while it has a molecular mass of 53.7 kDa following chemical reduction by S-carbamoylmethylation ([@bib124]). VaH3 cleaves basement membrane (BM) and extracellular matrix (ECM) proteins including type IV collagen, fibronectin and nidogen ([@bib124]). This data with the report of [@bib81] suggest that members of the P-IIIc class may be proteolytically potent against basal lamina and ECM proteins, although VaH3 can also cleave prothrombin and factor X without activating them ([@bib81]; [@bib124]). In addition, the dimers formed by the P-IIIc subclass can be constituted by two homologous monomers as in the case of VaH3 ([@bib124]) or by a heterodimer ([@bib158]). Complexation of some P-III class members with C-type lectin-like protein (Snaclecs) has been identified in the P-IIId subclass. In this subclass, a C-type lectin like domain is connected to the canonical P-III structure by a disulfide bridge ([@bib11]). RVV-X is a representative of the P-IIId subclass and it can be found in the Russel\'s viper venom (*Daboia russelii*). RVV-X sequence was completely reported by [@bib149] ([@bib149]). The unique 3D-structure of RVV-X has a hook-spanner-wrench configuration capable of binding to membrane receptors and coagulation factors instead of carbohydrates, demonstrating how important the relationship between structure and function is ([@bib145]). Moreover, RVV-X potently inhibited both ADP- and collagen-induced platelet aggregations, thereby causing intravascular coagulation in preys ([@bib149]). The complex 3D-structures of PIIIc and P-IIId members are related to enhanced pharmacological activity and toxicity ([@bib40]).

The four subclasses (P-IIIa, b, c, and d) are well-known and documented in the literature. However, studies suggested the existence of a P-IIIe subclass comprising proteins that lack the catalytic metalloproteinase domain ([@bib5]; [@bib83]). Although [@bib19] had previously correlated the evolutionary history of serpents to a repeated domain loss ([@bib19]), recent data from proteomic and transcriptomic analysis of *Vipera ammodytes ammodytes* venom identified Vaa-MPIII-3 as a member of the new P-IIIe subclass ([@bib83]). This protein is an apparent 21 kDa glycoprotein homologous to P-III SVMPs, lacking a metalloproteinase domain, thus consisting of only a partial disintegrin-like domain and an adjacent cysteine-rich domain ([@bib83]). [Fig. 3](#fig3){ref-type="fig"} represents the sub classification of the P-III class of SVMPs.Fig. 3Classification of the P-III SVMPs. P-IIIa has a metalloproteinase (M), a disintegrin-like (D) and a cysteine-rich (C) domain, displaying the canonical structure of P-III SVMPs. The D adjacent to the M domain of P-IIIb subclass is vulnerable to proteolytic cleavage. Members of the P-IIIc subclass form homo- or heterodimers connected by a disulfide bridge formed between the M domains of the two monomers. The P-IIId subclass represents a complexed P-III SVMP in which the C-terminal of the cysteine-rich domain is covalently linked to a tandem arrangement of two covalently bridged Snake C-type lectin-like regions-Snaclecs (c-L). The M domain is absent in the novel P-IIIe subclass and the processed form is a didomain containing D and C domains.Fig. 3

Previously in our laboratory, we reported the three dimensional structure of the protein bothropasin a P-III isolated from *Bothrops jararaca* venom ([@bib107]). Sequence alignment and comparative analysis with 41 other P-III SVMPs from NCBI revealed a significant pattern of sequence arrangement in the hyper-variable region (HVR) of members of this class ([@bib107]). A sub-group in the aligned sequences was highly homologous to bothropasin and showed a conserved sequence in the region of the so-called HVR, therefore referred to as highly conserved region -- HCR. This conserved sequence was very distinct from the HVR of the sub-group that encompasses the protein VAP1, suggesting that this HVR vary from one group to the other, but it is conserved within those of bothropasin. Considering these data, we proposed a new classification for the P-III class into two sub-groups, the P-III-HCR and the P-III-HVR ([@bib107]). Additionally, we have reported the transcriptome analysis of bioactive agents from the venom gland of *Bothrops alternatus* ([@bib36])*.* Although consistent with a previous report from literature ([@bib155]), we identified copies of venom prolyl endopeptidases in the venom gland. It is noteworthy to mention the presence of P73 and P123 prolyl residues preceded by conserved K72 and H122 residues in members of the P-III class ([@bib36]). This data suggest the presence of two prolyl endopeptidase cleavage sites only in P-III members, thereby further distinguishing the P-III class from the P--I and P-II classes. Additionally, we hypothesized that the P-III SVMPs may be cognate substrates of the venom prolyl endopeptidases ([@bib36]).

The ECD (glutamic, cystein, aspatic) motif is a putative collagen interacting motif present in the disintegrin-like domain of most of the P-III class members ([@bib49]; [@bib89]). Stejnihagin A and stejnihagin B are P-III representatives that were cloned from the venom of *Trimeresurus stejnegeri* ([@bib158]). Stejnihagin A has a SECD collagen interacting motif whereas stejnihagin B has a TECD collagen interacting motif. On the contrary, a few members of the P-III class contain the canonical RGD motif typical of the P-II class ([@bib93]). Even though they contain a motif peculiar to the disintegrins, till date there is no available data that have tentatively excluded them from P-III SVMPs. An example is BjussuMP-I, a P-III hemorrhagic metalloproteinase from *Bothrops jararacussu* venom ([@bib93]). The primary structure of this protein showed a conserved RGD-motif in the disintegrin-like domain. Activity reports showed that BjussuMP-I can induce lyses in fibrin clots and inhibit ADP- and collagen-induced platelet aggregations ([@bib93]).

Most members of the P-III class have a conserved stretch of six cysteinyl residues in their metalloproteinase domain as observed in stejnihagin A and B -- Cys^123^, Cys^163^, Cys^165^, Cys^170^, Cys^187^ and Cys^203^ ([@bib158]). However, studies have identified the seventh cysteinyl residue in some SVMPs, which may be responsible for additional activity of the proteins ([@bib47]). Some studies have correlated the presence of the seventh cysteinyl residue to vascular apoptosis-inducing activity ([@bib153]; [@bib164]). Additionally, this seventh cysteinyl residue may be conserved in the P-IIIb subclass since representatives of this subclass (including VAP1) have been demonstrated to potently induce apoptosis of vascular endothelial cells. [Fig. 4](#fig4){ref-type="fig"} shows the amino acid sequence of bothropasin, a PIII isolated from *B.jararaca* venom, with emphasis on the disulfide bridges ([@bib107]). [Table 3](#tbl3){ref-type="table"} shows the sub-classification of the P-III SVMPs and some examples of these proteins.Fig. 4Amino acid sequence of bothropasin, a PIII isolated from *B. jararaca* venom ([@bib107]). Cys residues that are in the form of disulfide bonds are shaded gray, numerated and connected by continuous lines. The free cysteine 189 is shaded in black. Calcium-binding sites as well as zinc-binding site are indicated and connected by dashed lines. Metalloproteinase (M), disintegrin (D) and cysteine-rich (C) domains.Fig. 4Table 3Sub-classification of P-III SVMPs and their activities.Table 3SVMPSub-classDomains in processed formsSnake SpeciesActivitiesReferences**1.**OhaginP-IIIaMetalloproteinase, disintegrin-like and cysteine rich domains*Ophiophagus hannah*Fibrinogenolytic activity and inhibition of ADP-induced platelet aggregation[@bib59]**2.**VaF1P-IIIaMetalloproteinase, disintegrin-like and cysteine rich domains*Vipera ammodytes ammodytes*α-fibrinogenase activity[@bib82]**3.**HR-Ele1P-IIIaMetalloproteinase, disintegrin-like and cysteine rich domains*Protobothrops elegans*Hemorrhagic, αβ-fibrinogenase, type I collagenase[@bib115]**4.**Atrolysin AP-IIIaMetalloproteinase, disintegrin-like and cysteine rich domains*Crotalus atrox*Hemorrhagic, proteolytic, degrades plasma fibronectin, type-I collagenase, type-IV collagenase, fibrinogenase, gelatinase, sheddase of glycoprotein VI,[@bib46], [@bib118]**5.**AlbocollagenaseP-IIIaMetalloproteinase, disintegrin-like and cysteine rich domains*Cryptelytrops albolaris*Inhibition of collagen-induced platelet aggregation, type IV collagenase[@bib119]**6.**Alternagin-CP-IIIbDisintegrin-like domain linked to a cysteine-rich domain*Bothrops alternatus*Inhibition of integrin-collagen interaction, inhibition of angiogenesis in HUVECs[@bib31], [@bib41], [@bib128], [@bib139]**7.**CatrocollastatinP-IIIbDisintegrin-like domain linked to a cysteine-rich domain*Crotalus atrox*Inhibition of collagen-induced platelet aggregation[@bib49], [@bib168]**8.**Baltergin-CP-IIIbDisintegrin-like domain linked to a cysteine-rich domain*Bothrops alternatus*Hemorrhagic, type IV collagenase[@bib53]**9.**SV-PAD-2P-IIIcDimeric; each monomer contains: a metalloproteinase, a disintegrin-like and a cysteine-rich domain*Protobothrops elegans*αβγ-fibrinogenase\
inhibition of ADP- and collagen-induced inhibition of platelet aggregation[@bib115]**10.**AHPMP-IIIcDimeric; each monomer contains: a metalloproteinase, a disintegrin-like and a cysteine-rich domain*Agkistrodon halys pallas*α-fibrinogenase, inhibition of ADP-induced platelet aggregation[@bib138]**11.**VaH3P-IIIcDimeric; each monomer contains: a metalloproteinase, a disintegrin-like and a cysteine-rich domain*Vipera ammodytes ammodytes*Proteolytic cleavage of prothrombin, X factor as well as BM and ECM protein components[@bib124]**12.**VaH4P-IIIcDimeric; each monomer contains: a metalloproteinase, a disintegrin-like and a cysteine-rich domain*Vipera ammodytes ammodytes*Hemorrhagic (hydrolysis of ECM proteins) and cytotoxic activities against Hela cells[@bib81]**13.**HV1P-IIIcDimeric; each monomer contains: a metalloproteinase, a disintegrin-like and a cysteine-rich domain*Trimeresurus flavoviridis*Apoptosis of vascular endothelial cell *in vitro*[@bib92]**14.**VAP1P-IIIcDimeric; each monomer contains: a metalloproteinase, a disintegrin-like and a cysteine-rich domain*Crotalus atrox*Fibrinogenolytic, Apoptosis of vascular endothelial cell *in vitro*[@bib91]**15.**VLFXAsP-IIIdMetalloproteinase, disintegrin-like, cysteine-rich and two C-type lectin-like domains*Vipera ammodytes ammodytes*Activation of coagulation factor X to Xa, inhibition of collagen-induced platelet aggregation[@bib80]**16.**RVV-XP-IIIdMetalloproteinase, disintegrin-like, cysteine-rich and two C-type lectin-like domains*Daboia russelli*Inhibition of both ADP- and collagen-induced platelet aggregations[@bib149]**17.**Vaa-MPIII-3P-IIIeDisintegrin-like and cysteine-rich domains*Vipera ammodytes ammodytes*Hemorrhagic[@bib83]

2. Domains functions {#sec2}
====================

The resolution of the three-dimensional structures of SVMPs domains were important to the characterization and classification of these metalloproteinases as well as to elucidate the relationship between the domains and their specific functions during snake envenomation. [Table 4](#tbl4){ref-type="table"} shows the SVMPs available in the Protein Data Bank (PDB), which 3D-structures were determined.Table 4Three-dimensional structures of SVMPs available in the Protein Data Bank (PDB).Table 4Protein (PDB)Snake SpeciesClass SVMPMethodReferences**Acutolysin A (1BUD)***Deinagkistrodon acutus*P-IX-ray[@bib57]**Acutolysin-C (1QUA)***Deinagkistrodon acutus*P-IX-ray[@bib171]**FII (1YP1)***Deinagkistrodon acutus*P-IX-ray[@bib87]**AaHIV (3HDB)***Deinagkistrodon acutus*P-IIIX-ray[@bib172]**Disintegrin (2M75)***Calloselasma rhodostoma*P-IIa (D-domain)NMR[@bib28]**Rhodostomin (Rho)** (2M7F, 2M7H, 4R5R, 3UCI, 4RQG, 4M4C, 4R5U, 14Y, 1Q7I, 1Q7J, 2LJV, 2M75, 2PJF, 2PJI)*Calloselasma rhodostoma*P-II (recombinant D-domain with and without mutations)NMR and X-ray[@bib24], [@bib69], [@bib136]**Atragin (3K7L)***Naja atra*P-IIIX-ray[@bib58]**K-like protein (3K7N)***Naja atra*P-IIIX-ray[@bib58]**Leucurolysin-A (4Q1L)***Bothrops leucurus*P-IX-ray[@bib45]**TM-1 (4J4M)***Protobothrops mucrosquamatus*P-IX-ray[@bib27]**BmooMPalpha-I (3GBO)***Bothrops moojeni*P-IX-ray[@bib3]**TM-3 complexed with pEKW (1KUK)***Protobothrops mucrosquamatus*P-IX-ray[@bib70]**TM-3 (1KUF)***Protobothrops mucrosquamatus*P-IX-ray[@bib70]**Bothropasin (3DSL)***Bothrops jararaca*P-IIIX-ray[@bib107]**VAP1 (2ERQ, 2ERP, 2ERO))***Crotalus atrox*P-IIIX-ray[@bib144]**VAP2** (2DW0, 2DW1, 2DW2)*Crotalus atrox*P-IIIX-ray[@bib71]**Disintegrin (1TEJ)***Echis carinatus*P-IIdX-ray[@bib9]**Acostatin (3C05)***Agkistrodon contortrix contortrix*P-IIeX-ray[@bib97]**Schistatin (1RMR)***Echis carinatus*P-IIdX-ray[@bib8]**Trimestatin (1JL2)***Protobothrops flavoviridis*P-IIa (D-domain)X-ray[@bib52]**Bitistatin A (2MOP)***Bitis arietans*P-IIa (D-domain)NMR[@bib18]**Bitistatin B (2MP5)***Bitis arietans*P-IIa (D-domain)NMR[@bib18]**Salmosin (1L3X)***Gloydius brevicaudus*P-IIa (D-domain)NMR[@bib135]**Echistatin (1RO3)***Echis carinatus*P-IIa (D-domain)NMR[@bib99]**Obtustatin (1MPZ)***Macrovipera lebetina obtusa*P-IIa (D-domain)NMR[@bib102]**Kistrin (1N4Y)***Calloselasma rhodostoma*P-IIa (D-domain)NMR[@bib2]**Jerdostatin** (2W9V, 2W9O, 2W9U, 2W9W)*Protobothrops jerdonii*P-IIa (recombinant D-domain)NMR[@bib17]**RVV-X (2E3X)***Daboia siamensis*P-IIIX-ray[@bib145]**Atrolysin-C (1HTD/1ATL)***Crotalus atrox*P-IX-ray[@bib166]**BaP1 (1ND1)***Bothrops asper*P-IX-ray[@bib161]**BaP1 complexed with a peptidomimetic (2W14)***Bothrops asper*P-IX-ray[@bib85]**Adamalysin II (1IAG)***Crotalus adamanteus*P-IX-ray[@bib55]**Flavoridin (1FVL)***Protobothrops flavoviridis*P-IIa (D-domain)NMR[@bib129]**H2-proteinase (1WN1)***Protobothrops flavoviridis*P-IX-ray[@bib79]**Disintegrin (1Z1X)***Echis carinatus*P-IIa (D-domain)X-ray[@bib62]

As previously described, studies have shown that some activities of SVMPs attributed to one of the domains are enhanced by the presence of another domain. In addition, we will provide a general description of the activities assigned to each domain in the following subsections.

2.1. Signal peptide and pro-domain {#sec2.1}
----------------------------------

Unprocessed SVMPs contain a signal sequence that serves as an export signal and a molecular address label ([@bib73]). Meanwhile the pro-domain contains a conserved stretch of PKMCGVT that controls maturation of SVMP by a cysteine switch mechanism ([@bib114]; [@bib146]).

2.2. Metalloproteinase domain {#sec2.2}
-----------------------------

The metalloproteinase domain of the SVMP classes represents the catalytically active domain of all the identified members. Three-dimensional structures of SVMPs revealed that this domain has an oblate ellipsoidal format with a small lower region and an upper main region containing the active site. Interesting, the C-terminal of the lower region is formed by a helix preceded by an irregular folded domain that is considered essential for substrate recognition ([@bib146]).

In the early part of this review, we have coalesced several reports that identified the presence of a zinc-binding scaffold in the M domain ([@bib7]; [@bib27]; [@bib32]; [@bib63]; [@bib77]; [@bib85]; [@bib117]). This identification validates that the biological activities of such domain solely depend on a zinc-aided catalysis. To further support this claim, researchers highlighted the presence of a unique HEXXHXXGXXH consensus sequence, which is responsible for coordinating the putative binding of zinc metal. The report that punctuated the loss of a metalloproteinase domain in the new P-IIIe subclass revealed its lack of metalloproteinase specific function/activities ([@bib83]). Put together, the function of this domain depends on the pentahedrally coordinated zinc reinforced by the unique sequence of methionine called the "methionine turn" (Met-turn) ([@bib89]).

Recently, an immunological probe assay unveiled the presence of a conserved sequence of 21 amino acids (KARMYELANIVNEILRYLYMH) constituting a B-cell epitope in the M domain ([@bib98]). This study hypothesized that the function of the M domain may be linked to immunological reaction involving migration of inflammatory cytokines and activation of various pathways underlining the pathological phenotype of snake envenomation ([@bib98]). However, more data are necessary to validate this assumption.

One of the most studied functions mediated by the metalloproteinase domain during snake envenomation is its hemorrhagic activity, which is marked by hydrolysis of basement membrane proteins, such as laminin and type IV collagen that surround endothelial cells in the capillaries leading to local hemorrhage and in some cases causing a systemic effect (bleeding) ([@bib37]). Interestingly, [@bib63] showed through an *ex vivo* model of mouse cremaster muscle tissue that P-II and P-III SVMPs co-localize with type IV collagen in capillaries and arterioles (microvessels) whereas P--I SVMPs has a widespread localization throughout the tissue. This difference in tissue localization is probably responsible for the high hemorrhagic activity of P-II and P-III members compared to the P--I class ([@bib63]). Moreover, the metalloproteinase domain is also important in non-hemorrhagic proteins, being associated with fibrino(geno)lytic and apoptosis inducing activities. In *in vitro* experiments, endothelial cell apoptosis is more pronounced after envenomation by non-hemorrhagic SVMPs ([@bib4]), and it occurs when the catalytic domain disrupts the molecular assembly formed between focal adhesions of endothelial cells and the extracellular matrix ([@bib39]). Such apoptotic mechanism may be underlined by alterations in the endothelial cell-integrin-extracellular matrix assembly resulted from metalloproteinase proteolytic activity. When such assembly is intact, the activities of certain proteins capable of triggering apoptosis remain suppressed.

Studies have also revealed the fibrino(geno)lytic activity of the metalloproteinase domain. There have been several reports of alteration in ligand-receptor interaction; such alteration corresponds to the ectodomain sheddase activities of this domain ([@bib66]; [@bib104]; [@bib106]). For instance, [@bib112] showed how atroxlysin-III from the Peruvian pit viper snake (*Bothrops oligolepis*) induced glycoprotein VI shedding, culminating into platelet dysfunction ([@bib113]). Previously, the sheddase activity of atrolysin a, a P-III SVMP from *Crotalus atrox* venom, was demonstrated against collagen IV and annexin in cultured human fibroblasts ([@bib118]). Similar effects were suggested for jararhagin, a P-III SVMP from *Bothrops jararaca* upon TNF-α precursor ([@bib104]).

2.3. Disintegrin and disintegrin-like domains {#sec2.3}
---------------------------------------------

The disintegrin and the disintegrin-like domains have been briefly described at the early part of this review. We have also provided evidences from literature about the presence of an integrin-binding motif in these domains, its peculiarity and its variants. It is well-know that almost all the P-III SVMPs have a disintegrin-like domain that contains a D/ECD-conserved motif instead of the canonical RGD-motif of the disintegrins (P-II class).

The function of both disintegrin and disintegrin-like domains is marked by the presence of the conserved motif. For example, the disintegrin domain of P-II SVMPs is responsible for platelet aggregation inhibition due to its binding to α~IIb~β~3~ integrin ([@bib91]; [@bib122]). Since integrins represent adhesive frameworks (although not exclusive); connecting the cellular cytoskeleton to extracellular matrix components, the interaction between disintegrins and integrins may also limit cell to cell and cell-ECM interactions. Interestingly, most of the activities of the disintegrins are marked by their interaction with integrins. Structurally, disintegrins can vary depending on the type of integrin-binding motif present in them and such variation may account for differences in target selection and substrate diversity ([@bib107]). Disintegrin-integrin interaction also depends on amino acid sequences present in the disintegrin loop (a structural feature that encloses the integrin binding motif), and in the C-terminus of the disintegrin. The presence of these two sequences culminated to variation in the integrin binding ([@bib23]).

In general, disintegrins can inhibit adhesion and migration of several cell lines. Recently, Montealegre-Sanchez and co-workers reported that Lansbermin-l, a low molecular weight RGD-disintegrin from *Porthidium lansbergii lansbergii*, inhibited the adhesion and migration of MCF7 and MDA-DB 231 breast cancer cells by interfering with α~2~ or β~1~-containing integrins ([@bib100]). Furthermore, [@bib22] characterized the RGD-disintegrin Dabmaurin-1 isolated from *Daboia mauritanica* snake. Dabmaurin-1 inhibited HMEC proliferation, adhesion and migration to several ECM components, as well as tube formation after interaction with β~1~-containing integrins ([@bib22]). Additionally, in our laboratory, we demonstrated that Dis*Ba*-01, a RGD-disintegrin, inhibited cell migration and adhesion in murine breast tumor cell line 4T1BM2. Our data confirmed that Dis*Ba*-01 hampered cell cycle progression at S phase and induced autophagy ([@bib86]). In addition, we demonstrated that the blockade of α~v~β~3~ integrin in oral squamous carcinoma cells by Dis*Ba*-01 inhibits cell directionality of migration ([@bib101]).

The presence of the non-catalytic disintegrin-like and cysteine-rich domains is strongly responsible for the hemorrhagic activity of the P-III class members ([@bib42]). Escalante and co-workers revealed that the activities of P-III SVMPs are not limited to their catalytic domain and that most of the activities may be in tandem or cumulatively mediated by more than one domain. This means that P-III SVMPs containing an intact metalloproteinase domain and a disintegrin-like domain may be more potent in their activities than those lacking the non-catalytic domain ([@bib42]). The ECD-containing disintegrin-like proteins of the P-III class have also been shown to inhibit the adhesion of cells to collagen ([@bib35]; [@bib74]; [@bib139]; [@bib141]; [@bib152]; [@bib169]).

It is important to highlight that 3D-structures of P-III SVMPs showed that the metalloproteinase domain alongside with the disintegrin-like and the cysteine-rich domains (MDC) form a C-shaped structure that places the HVR region of the cysteine-rich domain near to the catalytic site of the metalloproteinase domain. This is important to substrate recognition, because this C-shaped configuration allows a flexibility between the catalytic site and the exosite of P-III throughout the catalytic cycle ([@bib147]).

2.4. Cysteine-rich domain {#sec2.4}
-------------------------

Structural studies have shown that the cysteine-rich domain (C-domain) of bothropasin is formed by two α-helices, 4 β-strands and loops ([@bib107]; [@bib144]). The loop is stabilized by the presence of a disulfide bond found in the C-domain, which contain the hyper-variable region (HVR) or the highly-conserved region (HCR), depending on the specific subclass of P-III SVMPs ([@bib107]). Structural studies indicated that the C-domain could bind to a free- or membrane-bound target protein positioning the M domain to its substrate for proteolytic attack ([@bib144]). In addition, the HVR can have an essential role in protein-protein interactions, suggesting a structural correlation for the variety of biological activities found in the P-III class ([@bib147]). As mentioned before, the HVR localizes opposite to the catalytic site in the C-shaped MDC structure, thus it has been addressed with the function of substrate/peptide recognition ([@bib147]; [@bib146]). For instance, [@bib94] showed that the HVR of the C-domain formed a protein-to-protein adhesive framework capable of inducing leucocyte rolling in microcirculation ([@bib94]). In another study, they demonstrated through site directed mutagenesis that the HVR of this domain inhibited platelet aggregation ([@bib95]). Additionally, [@bib132] showed that the von Willebrand factor-mediated platelet aggregation was inhibited by the C-domain ([@bib132]). Solid-phase binding assay using type I collagen and vWF revealed that this domain contains exosites that can act as a cell-surface-receptor-binding site ([@bib130]), thereby revealing the role of the C-domain in the promotion of hemorrhage through substrate recognition, target selection and positioning of the metalloproteinase domain for its proteolytic activity ([@bib131]).

The C-domain also plays a critical role in inflammation. In functional association with the disintegrin-like domain, it has been shown to sufficiently cause leucocyte rolling and release of pro-inflammatory cytokines in the early stage of acute inflammatory response ([@bib30]). However, a recent report showed that the catalytic metalloproteinase domain of SVMPs is the principal effector of leucocyte recruitment, suggesting that the C-domain could also present an inflammatory response only in the absence of the M domain ([@bib173]). [Fig. 5](#fig5){ref-type="fig"} shows the summary of the SVMP domains and its functions.Fig. 5Summary of SVMP domains and their functions.Fig. 5

3. Concluding remark {#sec3}
====================

Snake Venom Metalloproteinases are diverse in both structure and activities. The most recent classification recognizes three classes: P--I, P-II and P-III, including sub-classification of P-II and P-III classes. Furthermore, advancement in protein characterization and sophistication in molecular techniques continue to avail scientists the opportunity to identify novel SVMPs and correlate activities to specific domains. However, the exact sub-domain structures responsible for these activities have only been speculated in some cases. In addition, despite the identification of novel SVMPs, not all have been properly classified, especially into the P-II and P-III sub-classes. Therefore, as the field of molecular toxinology advances, scientists should maximize the use of available tools to characterize and identify the exact sub-domain structures that are responsible for their specific activities; as this will not only permit proper classification, but also expand the current understanding on the contribution of SVMPs to snake envenomation. Snake genomics, transcriptomics and proteomics contribute qualitatively and quantitatively to studies of structure-function relationship of venom components, adding new information that ultimately help to characterize toxins, notably SVMPs. As the Venomics develops, our knowledge evolves, opening doors to new discoveries in the field.
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